Company / Operating Income
ACCENDRA HEALTH INC/VA/ Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$27.5M
FY2025
5-year range
-$217.7M / $142.9M
FY2021-FY2025
Trend
+112.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income returned to growth in FY2025 after 2 years of decline, reaching $27M.
Based on SEC 10-K filings.
$27M in FY2025 with a 5-year CAGR of -33.0%.
Declined from $133M to $27M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -42.3%
- 5-Year CAGR
- -33.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -33.0%, indicating a declining trend.
- In FY2025, operating income increased 112.6% year-over-year.
- Peak operating income was recorded in FY2020.
- Lowest operating income in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.60 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $27.5M | +112.6% |
| FY2024 | -$217.7M | -263.4% |
| FY2023 | $133.2M | -6.8% |
| FY2022 | $142.9M | +95.4% |
| FY2021 | $73.2M | -64.2% |
| FY2020 | $204.1M | +157.9% |
| FY2019 | -$352.3M | +0.0% |
| FY2018 | -$352.3M | -494.8% |
| FY2017 | $89.3M | -55.3% |
| FY2016 | $199.6M | -0.4% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026